• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成能否预测膀胱浅表性移行细胞癌的复发?

Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?

作者信息

Sağol O, Yörükoğlu K, Sis B, Tuna B, Ozer E, Güray M, Mungan U, Kirkali Z

机构信息

Department of Pathology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.

出版信息

Urology. 2001 May;57(5):895-9. doi: 10.1016/s0090-4295(01)00905-0.

DOI:10.1016/s0090-4295(01)00905-0
PMID:11337289
Abstract

OBJECTIVES

To investigate the role of angiogenesis in predicting tumor recurrence and its correlation with established clinicopathologic prognostic factors in superficial transitional cell carcinoma of the bladder.

METHODS

The paraffin sections of 80 superficial papillary transitional cell bladder carcinoma specimens were stained with CD31 antibody to label the vascular endothelium using the standard streptavidin-biotin-immunoperoxidase method. The vascular surface density (VSD) equivalent to the vascular surface area per unit of tissue volume and number of vessels per square millimeter of stroma (NVES) were assessed by means of stereology, and these morphometric parameters of angiogenesis were statistically analyzed to interpret the relation to tumor recurrence in addition to tumor stage, grade, size, and number and the presence of carcinoma in situ.

RESULTS

VSD and NVES values showed no statistically significant difference between pTa and pT1 tumors or patients with and without recurrence. In contrast, VSD and NVES values were found to increase in higher grade tumors (P = 0.019). VSD values were also higher in patients with coexisting carcinoma in situ in pTa tumors (P <0.001). Tumor number and size and recurrence number and time to the first recurrence did not correlate with any vascular parameters.

CONCLUSIONS

Stereologic assessment of angiogenesis does not help to predict recurrence in superficial bladder cancer. Angiogenic parameters appeared to be well correlated with the conventional histologic grading system. Otherwise, the present study did not show any correlation of angiogenesis with any potential prognostic factors. This may be due to the diverse angiogenic pathways occurring in invasive and superficial tumors.

摘要

目的

探讨血管生成在预测膀胱浅表性移行细胞癌肿瘤复发中的作用及其与既定临床病理预后因素的相关性。

方法

采用标准链霉亲和素-生物素-免疫过氧化物酶法,用CD31抗体对80例膀胱浅表乳头状移行细胞癌标本的石蜡切片进行染色,以标记血管内皮。通过体视学评估相当于单位组织体积血管表面积的血管表面密度(VSD)和每平方毫米基质中的血管数量(NVES),除了肿瘤分期、分级、大小、数量和原位癌的存在情况外,还对这些血管生成的形态学参数进行统计分析,以解释其与肿瘤复发的关系。

结果

pTa和pT1肿瘤之间或复发患者与未复发患者之间的VSD和NVES值无统计学显著差异。相比之下,发现高级别肿瘤的VSD和NVES值增加(P = 0.019)。pTa肿瘤中并存原位癌的患者VSD值也更高(P <0.001)。肿瘤数量和大小以及复发次数和首次复发时间与任何血管参数均无相关性。

结论

血管生成的体视学评估无助于预测浅表性膀胱癌的复发。血管生成参数似乎与传统组织学分级系统密切相关。此外,本研究未显示血管生成与任何潜在预后因素之间存在任何相关性。这可能是由于侵袭性和浅表性肿瘤中存在多种血管生成途径。

相似文献

1
Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?血管生成能否预测膀胱浅表性移行细胞癌的复发?
Urology. 2001 May;57(5):895-9. doi: 10.1016/s0090-4295(01)00905-0.
2
[Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer].浅表性膀胱癌中血管生成因子表达及肿瘤血管生成的免疫组织化学分析
Nihon Hinyokika Gakkai Zasshi. 1998 May;89(5):529-37. doi: 10.5980/jpnjurol1989.89.529.
3
Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer.血管生成、组织蛋白酶D和IV型胶原免疫反应性在高级别T1期原发性膀胱癌中的预后意义
Urology. 1999 Jul;54(1):50-5. doi: 10.1016/s0090-4295(99)00026-6.
4
Prognostic significance of angiogenesis in superficial bladder cancer.血管生成在浅表性膀胱癌中的预后意义。
Int Urol Nephrol. 2004;36(2):163-7. doi: 10.1023/b:urol.0000034676.50636.e0.
5
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.膀胱癌中的血管生成:微血管密度与肿瘤预后的关系。
J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12. doi: 10.1093/jnci/87.21.1603.
6
The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.浅表性膀胱癌患者初诊时肾盂积水的发生率及其对复发和进展的影响。
J Urol. 2007 Sep;178(3 Pt 1):802-6; discussion 806. doi: 10.1016/j.juro.2007.05.054. Epub 2007 Jul 16.
7
Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis.微血管密度作为膀胱癌的预后标志物:与肿瘤分级、分期及预后的相关性
Int Urol Nephrol. 2004;36(3):401-5. doi: 10.1007/s11255-004-8869-9.
8
Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer.形态学微血管特征可预测浅表性和浸润性膀胱癌的预后。
Virchows Arch. 2001 Jun;438(6):603-11. doi: 10.1007/s004280100400.
9
Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.Maspin在非肌层浸润性膀胱癌中的表达:与肿瘤血管生成及预后的相关性
Eur Urol. 2004 Jun;45(6):737-43. doi: 10.1016/j.eururo.2003.12.005.
10
Prognostic relevance of micro-vessel density in cancer of the urinary bladder.
Anticancer Res. 1999 Jul-Aug;19(4C):3479-84.

引用本文的文献

1
CEUS in the differentiation between low and high-grade bladder carcinoma.对比增强超声在低级别和高级别膀胱癌鉴别诊断中的应用
J Ultrasound. 2012 Sep 24;15(4):247-51. doi: 10.1016/j.jus.2012.09.002. Print 2012 Dec.
2
Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31.免疫组织化学染色因子 VIII 和 CD31 后,微血管密度 (MVD) 定义的膀胱癌中的血管生成。
Libyan J Med. 2011 Mar 31;6. doi: 10.3402/ljm.v6i0.6016.
3
Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.
p53 缺失和血管生成 microRNA 谱的获得不足以促进膀胱尿路上皮原位癌进展为浸润性癌。
J Biol Chem. 2011 Jun 10;286(23):20778-87. doi: 10.1074/jbc.M110.198069. Epub 2011 Mar 9.
4
Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer.埃及膀胱癌患者中的血管内皮生长因子、p53 和 H-ras 癌基因。
World J Gastrointest Oncol. 2009 Oct 15;1(1):62-8. doi: 10.4251/wjgo.v1.i1.62.
5
Current status and perspective of antiangiogenic therapy for cancer: urinary cancer.癌症抗血管生成治疗的现状与展望:泌尿系统癌症
Int J Clin Oncol. 2006 Apr;11(2):90-107. doi: 10.1007/s10147-006-0565-6.
6
Tumour angiogenic activity and vascular survival ability in bladder carcinoma.膀胱癌中的肿瘤血管生成活性和血管存活能力。
J Clin Pathol. 2004 Mar;57(3):250-5. doi: 10.1136/jcp.2003.012005.